Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2023-01-17 00:00:00 ET · period of report 2023-01-15 · accession 0001055726-23-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-17 | 2023-01-15 | INO | Shepard Jay | Dir | M - OptEx | — | +4,273 | 39.5K | +12% | — |
| D | 2023-01-17 | 2023-01-15 | INO | Shepard Jay | Dir | M - OptEx | $0.00 | -4,273 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-15 | M | A | 4,273 | — | 39,521 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on January 15, 2021; 4,274 shares vested on January 15, 2022; 4,273 shares vested on January 15, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both |
| 2 | Derivative | Restricted Stock Unit | 2023-01-15 | M | D | 4,273 | $0.00 | 0 | D | — · — to — | 4,273 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on January 15, 2021; 4,274 shares vested on January 15, 2022; 4,273 shares vested on January 15, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both |